611
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Survey on Genetic Diversity, Biofilm Formation, and Detection of Colistin Resistance Genes in Clinical Isolates of Acinetobacter baumannii

, , &
Pages 1547-1558 | Published online: 27 May 2020

References

  • Wareth G, Neubauer H, Sprague LD. Acinetobacter baumannii–a neglected pathogen in veterinary and environmental health in Germany. Vet Res Commun. 2019;43(1):1–6. doi:10.1007/s11259-018-9742-030591981
  • Hatami R. The frequency of multidrug-resistance and extensively drug-resistant Acinetobacter baumannii in west of Iran. J Clin Microbiol Infect Dis. 2018;2:1.
  • Hassannejad N, Bahador A, Hayati Rudbari N, Modarressi MH, Parivar K. Comparison of OmpA gene-targeted real-time PCR with the conventional culture method for detection of Acinetobacter baumanii in pneumonic BALB/c mice. Iran Biomed J. 2019;23(2):159–164. doi:10.29252/ibj.23.2.15930665275
  • Batarseh A, Al-Sarhan A, Maayteh M, Al-Khatirei S, Alarmouti M. Antibiogram of multidrug resistant Acinetobacter baumannii isolated from clinical specimens at King Hussein Medical Centre, Jordan: a retrospective analysis. East Mediterr Health J. 2015;21(11):11. doi:10.26719/2015.21.11.828
  • Rezaei E, Safari H, Naderinasab M, Aliakbarian H. Common pathogens in burn wound and changes in their drug sensitivity. Burns. 2011;37(5):805–807. doi:10.1016/j.burns.2011.01.01921388742
  • Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65(2):233–238. doi:10.1093/jac/dkp42819996144
  • Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother. 2012;67(7):1607–1615. doi:10.1093/jac/dks08422441575
  • Ahmed SS, Alp E, Hopman J, Voss A. Global epidemiology on colistin resistant Acinetobacter baumannii. J Infect Dis. 2016.
  • Moffatt JH, Harper M, Adler B, et al. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(6):3022–3024. doi:10.1128/AAC.01732-1021402838
  • Thummeepak R, Kongthai P, Leungtongkam U, Sitthisak S. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. Int Microbiol. 2016;19(2):121–129. doi:10.2436/20.1501.01.27027845499
  • Fattahian Y, Rasooli I, Gargari SL, Rahbar MR, Astaneh SD, Amani J. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog. 2011;51(6):402–406. doi:10.1016/j.micpath.2011.09.00421946278
  • Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiol. 2008;154(11):3398–3409. doi:10.1099/mic.0.2008/019471-0
  • Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One4. 2010;e10034. doi:10.1371/journal.pone.0010034
  • Pourcel C, Minandri F, Hauck Y, et al. Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J Clin Microbiol. 2011;49(2):539–548. doi:10.1128/JCM.02003-1021147956
  • Hauck Y, Soler C, Jault P, et al. Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis. PLoS One. 2012;7(9):e44597. doi:10.1371/journal.pone.004459722984530
  • Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. Washington DC: American Society for Microbiology; 2006.
  • Higgins PG, Wisplinghoff H, Krut O, Seifert H. A PCR‐based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect. 2007;13(12):1199–1201. doi:10.1111/j.1469-0691.2007.01819.x17850345
  • CLSI. M100-S28. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Eight Informational Supplement. 2018.
  • Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol. 2007;45(1):227–230. doi:10.1128/JCM.01588-0617093026
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug resistant, extensively drug resistant and pan drug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiology Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
  • Azizi O, Shahcheraghi F, Salimizand H, et al. Molecular analysis and expression of bap gene in biofilm-forming multi-drug-resistant Acinetobacter baumannii. Rep Biochem Mol Biol. 2016;5(1):62.28070537
  • Li S, Duan X, Peng Y, Rui Y. Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China. BMC Infect Dis. 2019;19(1):900. doi:10.1186/s12879-019-4423-331660862
  • Haeili M, Kafshdouz M, Feizabadi MM. Molecular mechanisms of colistin resistance among pandrug-resistant isolates of Acinetobacter baumannii with high case-fatality rate in intensive care unit patients. Microb Drug Resist. 2018;24(9):1271–1276. doi:10.1089/mdr.2017.039729590004
  • Gomaa F, Helal Z, Khan M. High prevalence of blaNDM-1, blaVIM, qacE, and qacEΔ1 genes and their association with decreased susceptibility to antibiotics and common hospital biocides in clinical isolates of Acinetobacter baumannii. Microorganisms. 2017;5(2):18. doi:10.3390/microorganisms5020018
  • O’Toole GA. Microtiter dish biofilm formation assay. JoVE (J Vis Exp). 2011;(47):e2437.
  • Zhang D, Xia J, Xu Y, et al. Biological features of biofilm-forming ability of Acinetobacter baumannii strains derived from 121 elderly patients with hospital-acquired pneumonia. Clin Exp Med. 2016;16(1):73–80. doi:10.1007/s10238-014-0333-225543268
  • Turton JF, Gabriel SN, Valderrey C, et al. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect. 2007;13(8):807–815. doi:10.1111/j.1469-0691.2007.01759.x17610600
  • Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodríguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43(9):4382–4390. doi:10.1128/JCM.43.9.4382-4390.200516145081
  • Sato Y, Unno Y, Miyazaki C, Ubagai T, Ono Y. Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages. Sci Rep. 2019;9(1):1–2. doi:10.1038/s41598-019-53846-330626917
  • Jal’oot AS, Al-Ouqaili MT, Badawy AS. Molecular and bacteriological detection of multi-drug resistant and metallo-β–lactamase producer Acinetobacter baumannii in Ramadi City, West of Iraq. West Iraq Anb Med J. 2016;13:1–3.
  • Noori M, Mohsenzadeh B, Bahramian A, Shahi F, Mirzaei H, Khoshnood S. Characterization and frequency of antibiotic resistance related to membrane porin and efflux pump genes among Acinetobacter baumannii strains obtained from burn patients in Tehran, Iran. J Acute Dis. 2019;8(2):63–66.
  • Salehi B, Goudarzi H, Nikmanesh B, Houri H, Alavi-Moghaddam M, Ghalavand Z. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. J Infect Chem. 2018;24(7):515–523. doi:10.1016/j.jiac.2018.02.009
  • Khalilzadegan S, Sade M, Godarzi H, et al. Beta-lactamase encoded genes blaTEM and blaCTX among Acinetobacter baumannii species isolated from medical devices of intensive care units in Tehran hospitals. Jundishapur J Microbiol. 2016;9(5):e14990. doi:10.5812/jjm.1499027540447
  • Ferreira AE, Marchetti DP, Cunha GR, et al. Molecular characterization of clinical multiresistant isolates of Acinetobacter sp. from hospitals in Porto Alegre, State of Rio Grande do Sul, Brazil. Rev Soc Bras Med Trop. 2011;44(6):725–730. doi:10.1590/S0037-8682201100060001422231246
  • Uwingabiye J, Frikh M, Lemnouer A, et al. Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units. Pan Afr Med J. 2016;23:191. doi:10.11604/pamj.2016.23.191.791527347280
  • Ezadi F, Jamali A, Heidari A, Javid N, Ardebili A. Heteroresistance to colistin in oxacillinases-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran. J Glob Antimicrob Resist. 2019. doi:10.1016/j.jgar.2019.11.010
  • Hameed F, Khan MA, Muhammad H, Sarwar T, Bilal H, Rehman TU. Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan. Rev Soc Bras Med Trop. 2019;52:e20190237. doi:10.1590/0037-8682-0237-201931508785
  • Abdalhamid B, Hassan H, Itbaileh A, Shorman M. Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiol. 2014;37(1):65–73.24531172
  • Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications. Molecules. 2018;23(4):795. doi:10.3390/molecules23040795
  • Dortet L, Potron A, Bonnin RA, et al. Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria. Sci Rep. 2018;8(1):1–5. doi:10.1038/s41598-018-35041-y29311619
  • Al-Kadmy IM, Ibrahim SA, Al-Saryi N, Aziz SN, Besinis A, Hetta HF. Prevalence of genes involved in colistin resistance in Acinetobacter baumannii: first report from Iraq. Microb Drug Resist. 2019. doi:10.1089/mdr.2019.0243
  • Martins-Sorenson N, Snesrud E, Xavier DE, et al. A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain. J Antimicrob Chemother. 2020;75(1):60–64. doi:10.1093/jac/dkz41331578567
  • Bitar I, Medvecky M, Gelbicova T, et al. Complete nucleotide sequences of mcr-4.3-carrying plasmids in Acinetobacter baumannii sequence type 345 of human and food origin from the Czech Republic, the First Case in Europe. Antimicrob Agents Chemother. 2019;63(10):e01166–19. doi:10.1128/AAC.01166-1931332072
  • Rahman M, Ahmad S. 549. First report for emergence of chromosomal borne colistin resistance gene mcr-1 in a clinical acinetobacter baumannii isolates from India. Open Forum Infect Dis. 2019;6(Supplement_2):S261–S262. doi:10.1093/ofid/ofz360.618
  • Park YK, Choi JY, Shin D, Ko KS. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int J Antimicrob Agents. 2011;37(6):525–530. doi:10.1016/j.ijantimicag.2011.02.00821497062
  • Sepahvand S, Davarpanah MA, Roudgari A, Bahador A, Karbasizade V, Jahromi ZK. Molecular evaluation of colistin-resistant gene expression changes in Acinetobacter baumannii with real-time polymerase chain reaction. Infect Drug Resist. 2017;10:455–462. doi:10.2147/IDR.S14119629225477
  • Lean SS, Suhaili Z, Ismail S, et al. Prevalence and genetic characterization of polymyxin-resistant Acinetobacter baumannii isolated from a tertiary hospital in Terengganu, Malaysia. ISRN Microbiol. 2014;2014:953417. doi:10.1155/2014/95341725006521
  • Zeighami H, Valadkhani F, Shapouri R, Samadi E, Haghi F. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infect Dis. 2019;19(1):629. doi:10.1186/s12879-019-4272-031315572
  • Monfared AM, Rezaei A, Poursina F, Faghri J. Detection of genes involved in biofilm formation in MDR and XDR Acinetobacter baumannii isolated from human clinical specimens in Isfahan, Iran. Arch Clin Infect Dis. 2019;14(2):e85766.
  • Sung JY, Koo SH, Kim S, Kwon GC. Persistence of multidrug resistant Acinetobacter baumannii isolates harboring blaOXA-23 and bap for 5 years. J Microbiol Biotechnol. 2016;26(8):1481–1489. doi:10.4014/jmb.1604.0404927221112
  • Bardbari AM, Arabestani MR, Karami M, Keramat F, Alikhani MY, Bagheri KP. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates. Microb Pathog. 2017;108:122–128. doi:10.1016/j.micpath.2017.04.03928457900
  • Matsui M, Suzuki M, Suzuki M, et al. Distribution and molecular characterization of Acinetobacter baumannii international clone II lineage in Japan. Antimicrob Agents Chemother. 2018;62(2):e02190–17. doi:10.1128/AAC.02190-1729203489
  • Martins N, Dalla-Costa L, Uehara AA, Riley LW, Moreira BM. Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion. Infect Genet Evol. 2013;20:378–380. doi:10.1016/j.meegid.2013.09.02824121023
  • Bahador A, Farshadzadeh Z, Raoofian R, et al. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation. Ann Clin Microbiol Antimicrob. 2018;17(1):24. doi:10.1186/s12941-018-0277-629859115
  • Rafei R, Dabboussi F, Hamze M, et al. Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods. PLoS One. 2014;9(12):e115969. doi:10.1371/journal.pone.011596925541711
  • Farshadzadeh Z, Hashemi FB, Rahimi S, et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol. 2015;6:1146. doi:10.3389/fmicb.2015.0114626539176
  • Hojabri Z, Pajand O, Bonura C, Aleo A, Giammanco A, Mammina C. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J Antimicrob Chemother. 2014;69(9):2383–2387. doi:10.1093/jac/dku04524562615
  • Chang Y, Luan G, Xu Y, et al. Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital. Front Microbiol. 2015;6:910. doi:10.3389/fmicb.2015.0091026388854